Screening and Evaluation of Computationally Predicted JAK1-Binding Candidates from Multi-Source Chemical Space Using Deep Learning and Generative Models

Background/Objectives: Janus kinase 1 (JAK1) is a key mediator in inflammatory and autoimmune signaling pathways and represents a validated therapeutic target. Despite the availability of several JAK inhibitors, challenges in safety and efficacy persist, necessitating further computational prioritization of candidate molecules. Methods: We developed an integrated virtual screening workflow combining ensemble deep learning scoring (KPGT, KarmaDock, DrugCLIP), ADMET-AI filtering, and AutoDock Vina (v1.2.3) docking. The workflow was applied to the NPBS Atlas natural-product database and to molecules generated by 3DSMILES-GPT. Selected candidates were further evaluated by molecular dynamics simulations, DFT calculations, and synthetic accessibility assessment, with Filgotinib used as a reference compound. Results: Three natural-product-derived and three AI-generated molecules were prioritized. Among them, the MM-PBSA-estimated binding free energies were −26.251 kcal/mol for NPBS_111591, −19.858 kcal/mol for 3DSMILES_17365, and −19.593 kcal/mol for 3DSMILES_38767, compared with −29.253 kcal/mol for the reference compound Filgotinib. These MM-PBSA values were obtained under the same computational protocol and can provide relative computational comparisons, but pharmacological potency still requires validation by IC50 or biochemical binding assays. Conclusions: The study prioritizes computationally predicted JAK1-binding candidates and provides a multi-stage in silico workflow for further experimental evaluation.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-11-13
DOI
https://doi.org/10.3390/ph19111800
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Screening and Evaluation of Computationally Predicted JAK1-Binding Candidates from Multi-Source Chemical Space Using Deep Learning and Generative Models

Weiwei Han, Vivian Huerta, Shu Xing, Shiying Li et al.
3 links
Pharmaceuticals
Computational Drug Discovery Methods
article

Screening and Evaluation of Computationally Predicted JAK1-Binding Candidates from Multi-Source Chemical Space Using Deep Learning and Generative Models

Weiwei Han, Vivian Huerta, Shu Xing, Shiying Li, Jing Li
article en

Abstract

Background/Objectives: Janus kinase 1 (JAK1) is a key mediator in inflammatory and autoimmune signaling pathways and represents a validated therapeutic target. Despite the availability of several JAK inhibitors, challenges in safety and efficacy persist, necessitating further computational prioritization of candidate molecules. Methods: We developed an integrated virtual screening workflow combining ensemble deep learning scoring (KPGT, KarmaDock, DrugCLIP), ADMET-AI filtering, and AutoDock Vina (v1.2.3) docking. The workflow was applied to the NPBS Atlas natural-product database and to molecules generated by 3DSMILES-GPT. Selected candidates were further evaluated by molecular dynamics simulations, DFT calculations, and synthetic accessibility assessment, with Filgotinib used as a reference compound. Results: Three natural-product-derived and three AI-generated molecules were prioritized. Among them, the MM-PBSA-estimated binding free energies were −26.251 kcal/mol for NPBS_111591, −19.858 kcal/mol for 3DSMILES_17365, and −19.593 kcal/mol for 3DSMILES_38767, compared with −29.253 kcal/mol for the reference compound Filgotinib. These MM-PBSA values were obtained under the same computational protocol and can provide relative computational comparisons, but pharmacological potency still requires validation by IC50 or biochemical binding assays. Conclusions: The study prioritizes computationally predicted JAK1-binding candidates and provides a multi-stage in silico workflow for further experimental evaluation.

PharmaceuticalsVol. 19(11)
Jilin University (CN)
National Natural Science Foundation of China
Good health and well-being
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon